DK3512876T3 - Faktor viia-glycoformer - Google Patents

Faktor viia-glycoformer Download PDF

Info

Publication number
DK3512876T3
DK3512876T3 DK17851361.0T DK17851361T DK3512876T3 DK 3512876 T3 DK3512876 T3 DK 3512876T3 DK 17851361 T DK17851361 T DK 17851361T DK 3512876 T3 DK3512876 T3 DK 3512876T3
Authority
DK
Denmark
Prior art keywords
glycoformer
factor viia
viia
factor
viia glycoformer
Prior art date
Application number
DK17851361.0T
Other languages
English (en)
Inventor
Richard Ira Feldman
Original Assignee
Coagulant Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coagulant Therapeutics Corp filed Critical Coagulant Therapeutics Corp
Application granted granted Critical
Publication of DK3512876T3 publication Critical patent/DK3512876T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
DK17851361.0T 2016-09-13 2017-09-11 Faktor viia-glycoformer DK3512876T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662393930P 2016-09-13 2016-09-13
PCT/US2017/050887 WO2018052827A1 (en) 2016-09-13 2017-09-11 Factor viia glycoforms

Publications (1)

Publication Number Publication Date
DK3512876T3 true DK3512876T3 (da) 2021-11-15

Family

ID=61620165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17851361.0T DK3512876T3 (da) 2016-09-13 2017-09-11 Faktor viia-glycoformer

Country Status (12)

Country Link
US (1) US20190211319A1 (da)
EP (1) EP3512876B1 (da)
JP (1) JP2019530672A (da)
KR (1) KR20190045350A (da)
CN (1) CN109963866A (da)
CA (1) CA3036527A1 (da)
DK (1) DK3512876T3 (da)
ES (1) ES2902645T3 (da)
MX (1) MX2019002734A (da)
PL (1) PL3512876T3 (da)
SG (2) SG11201901989VA (da)
WO (1) WO2018052827A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118995880A (zh) * 2024-09-05 2024-11-22 北京国科星联科技有限公司 一种检测唾液酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
CN103627670B (zh) 2004-02-13 2016-12-21 格莱克托普有限公司 高活性糖蛋白加工条件及其有效生产方法
EP1761630A2 (en) 2004-06-21 2007-03-14 Novo Nordisk Health Care AG Glycosylation-disrupted factor vii variants
PT1841863E (pt) 2005-01-14 2010-10-25 Bayer Healthcare Llc Método para a purificação de factor vii
EP1816201A1 (en) * 2006-02-06 2007-08-08 CSL Behring GmbH Modified coagulation factor VIIa with extended half-life
MX2009007139A (es) * 2006-12-28 2009-10-08 Centocor Ortho Biotech Inc Metodos y vectores para generar inmunoglobulinas no sialiladas.
UA110323C2 (en) * 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
US20130243744A1 (en) * 2011-01-06 2013-09-19 Michael J. Betenbaugh Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
WO2013017555A1 (en) * 2011-08-01 2013-02-07 Lfb-Biotechnologies Factor vii compositions with specific glycosylation for controlled half-life
BR112015015182B1 (pt) * 2012-12-24 2023-12-26 Coagulant Therapeutics Corporation Variante polipeptídica isolada do fator vii, seu método de preparação e seu uso, e composições farmacêuticas e seus usos

Also Published As

Publication number Publication date
PL3512876T3 (pl) 2022-02-14
MX2019002734A (es) 2019-05-27
EP3512876B1 (en) 2021-10-27
CA3036527A1 (en) 2018-03-22
ES2902645T3 (es) 2022-03-29
JP2019530672A (ja) 2019-10-24
WO2018052827A1 (en) 2018-03-22
KR20190045350A (ko) 2019-05-02
SG11201901989VA (en) 2019-04-29
EP3512876A4 (en) 2020-04-22
EP3512876A1 (en) 2019-07-24
SG10202112746PA (en) 2021-12-30
CN109963866A (zh) 2019-07-02
US20190211319A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
EP3426163A4 (en) Retractor
DK3405050T3 (da) Børnesikret snusbeholder
EP3440949A4 (en) FLAVOR INHALER
EP3446605A4 (en) HAND VACUUM
DK3436823T3 (da) Antigen-array
EP3445380C0 (en) BACTERIOTHERAPY
DK3335532T3 (da) Tandharve
DK3402792T3 (da) Quinolin-2-on-derivater
EP3515414A4 (en) COMBINATION THERAPY
EP3402022A4 (en) GRAB WIRE
DK3445708T3 (da) Stigbøjle
EP3402021A4 (en) GRAB WIRE
DK3452590T3 (da) Plademagnet
DK3509963T3 (da) Pallecontainer
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
DK3575238T3 (da) Pallecontainer
EP3399976C0 (en) BENZOTHIAZOLE AMPHOPHILES
DE112017000734A5 (de) Glycolsensor
DE112017006386A5 (de) Schraubarbeitszylinder
DK3323708T3 (da) Bovfender
DK3430609T3 (da) Smartflag
DK3452587T3 (da) Penicillin-g-acylaser
EP3434648A4 (en) ZIRCONIUM OXIDE NANOPARTICLE
DK3471535T3 (da) Dyrelift
DE112017005767A5 (de) Nasslaufende lamellenkupplung